|
1
|
Ogawa Y, Yamashita T, Masunaga S, Kariya
S, Tokuhiro S, Aoyama N, Tsuzuki A, Yaogawa S, Kubota K, Nishioka
A, et al: A new enzyme-targeting and radio-sensitization treatment;
basics and clinical practice of KORTUC Shinoharashinsha Pub. Inc.,
Tokyo, 2015 (In Japanese).
|
|
2
|
Ogawa Y, Takahashi T, Kobayashi T, Kariya
S, Nishioka A, Hamasato S, Moriki T, Seguchi H, Yoshida S and
Sonobe H: Immunocytochemical characteristics of human osteosarcoma
cell line HS-Os-1: Possible implication in apoptotic resistance
against irradiation. Int J Mol Med. 14:397–403. 2004.PubMed/NCBI
|
|
3
|
Kariya S, Sawada K, Kobayashi T, Karashima
T, Shuin T, Nishioka A and Ogawa Y: Combination treatment of
hydrogen peroxide and X-rays induces apoptosis in human prostate
cancer PC-3 cells. Int J Radiat Oncol Biol Phys. 75:449–454.
2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ogawa Y, Takahashi T, Kobayashi T, Toda M,
Nishioka A, Kariya S, Seguchi H, Yamamoto H and Yoshida S:
Comparison of radiation-induced reactive oxygen species formation
in adult articular chondrocytes and that in human peripheral T
cells: Possible implication in radiosensitivity. Int J Mol Med.
11:455–459. 2003.PubMed/NCBI
|
|
5
|
Ogawa Y: Paradigm shift in radiation
biology/radiation oncology-exploitation of the
‘H2O2 Effect’ for radiotherapy using low-LET
(Linear Energy Transfer) Radiation such as X-rays and high-energy
electrons. Cancers (Basel). 8(28)2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ogawa Y, Kubota K, Aoyama N, Yamanishi T,
Kariya S, Hamada N, Nogami M, Nishioka A, Onogawa M and Miyamura M:
Non-surgical breast-conserving treatment (KORTUC-BCT) using a new
radio-sensitization method (KORTUC II) for patients with stage I or
II breast cancer. Cancers (Basel). 7:2277–2289. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Nimalasena S, Gothard L, Anbalagan S,
Allen S, Sinnett V, Mohammed K, Kothari G, Musallam A, Lucy C, Yu
S, et al: Intratumoral hydrogen peroxide with radiation therapy in
locally advanced breast cancer: Results from a phase 1 clinical
trial. Int J Radiat Oncol Biol Phys. 108:1019–1029. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tokuhiro S, Ogawa Y, Tsuzuki K, Akima R,
Ue H, Kariya S and Nishioka A: Development of a new
enzyme-targeting radiosensitizer (KORTUC) containing hydrogen
peroxide for intratumoral injection for patients with low linear
energy transfer (LET) radioresistant neoplasms. Oncol Lett.
1:1025–1028. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Christensen ES: Iatrogenic dissemination
of tumor cells-dissemination of tumor cells along the needle track
after percutaneous, transthoracic lung biopsy. Dan Med Bull.
25:82–87. 1978.PubMed/NCBI
|
|
10
|
Sinner WN and Zajicek J: Implantation
metastasis after percutaneous transthoracic needle aspiration
biopsy. Acta Radiol Diagn (Stockh). 17:473–480. 1976.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
National Cancer Institute (NCI): Common
Terminology Criteria for Adverse Events (CTCAE) v4.0. https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/.
Accessed November 25, 2021.
|
|
13
|
Gebski V, Lagleva M, Keech A, Simes J and
Langlands AO: Survival effects of postmastectomy adjuvant radiation
therapy using biologically equivalent doses: A clinical
perspective. J Natl Cancer Inst. 98:26–38. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
ECOG-ACRIN cancer Research Group: ECOG
Performance Status. https://ecog-acrin.org/resources/ecog-performance-status.
Accessed November 25, 2021.
|
|
15
|
Obata S, Ogihara Y, Ohta Y, Kan T, Kanegae
S, Inoue Y, Kuroiwa A, Inoue K, Yamanishi M, Hayashi T, et al:
Possibility of a ‘sentinel effect’ in chemoradiotherapy and a new
radiosensitizer injection (KORTUC). Jpn J Clin Radiol. 63:317–327.
2018.(In Japanese).
|
|
16
|
U.S. Food and Drug Administration: KYMRIAH
(tisagenlecleucel) https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/kymriah-tisagenlecleucel.
Accessed November 25, 2021.
|
|
17
|
Vaupel P: The role of hypoxia-induced
factors in tumor progression. Oncologist. 9 (Suppl 5):S10–S17.
2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Clevers H: The cancer stem cell: Premises,
promises and challenges. Nat Med. 17:313–319. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Li L and Bhatia R: Stem cell quiescence.
Clin Cancer Res. 17:4936–4941. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Takeishi S, Matsumoto A, Onoyama I, Naka
K, Hirao A and Nakayama KI: Ablation of Fbxw7 eliminates
leukemia-initiating cells by preventing quiescence. Cancer Cell.
23:347–361. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Iriuchishima H, Takubo K, Matsuoka S,
Onoyama I, Nakayama KI, Nojima Y and Suda T: Ex vivo maintenance of
hematopoietic stem cells by quiescence induction through Fbxw7 and
alpha; overexpression. Blood. 117:2373–2377. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Taniyama Y and Griendling KK: Reactive
oxygen species in the vasculature: Molecular and cellular
mechanisms. Hypertension. 42:1075–1081. 2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Pizzino G, Irrera N, Cucinotta M, Pallio
G, Mannino F, Arcoraci V, Squadrito F, Altavilla D and Bitto A:
Oxidative stress: Harms and benefits for human health. Oxid Med
Cell Longev. 2017(8416763)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kobayashi M and Harada H: Hypoxic stress
and HIF. Seikagaku. 85:187–195. 2013.PubMed/NCBI(In Japanese).
|
|
25
|
Ogawa Y, Ue H, Tsuzuki K, Tadokoro M,
Miyatake K, Sasaki T, Yokota N, Hamada N, Kariya S, Hitomi J, et
al: New radio-sensitization treatment (KORTUC I) using hydrogen
peroxide solution-soaked gauze bolus for unresectable and
superficially exposed neoplasms. Oncol Rep. 19:1389–1394.
2008.PubMed/NCBI
|
|
26
|
Miyatake K, Kubota K, Ogawa Y, Hamada N,
Murata Y and Nishioka A: Non-surgical care for locally advanced
breast cancer: Radiologically assessed therapeutic outcome of a new
enzyme-targeting radio-sensitization treatment, Kochi
Oxydol-radiation therapy for unresectable Carcinomas, Type II
(KORTUC II) with systemic chemotherapy. Oncol Rep. 24:1161–1168.
2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ogawa Y, Kubota K, Ue H, Tadokoro M,
Matsui R, Yamanishi T, Hamada N, Kariya S, Nishioka A, Nakajima H,
et al: Safety and effectiveness of a new enzyme-targeting
radio-sensitization treatment (KORTUC II) for intratumoral
injection for low-LET radio-resistant tumors. Int J Oncol.
39:553–560. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chapman JD, Dugle DL, Reuvers AP, Meeker
BE and Borsa J: Studies on the radio-sensitizing effect of oxygen
in Chinese hamster cells. Int J Radiat Biol Relat Stud Phys Chem
Med. 26:383–389. 1974.PubMed/NCBI View Article : Google Scholar
|
